Apothecon Pharmaceuticals Private Limited

Apothecon Pharmaceuticals Private Limited - pharma in Padra, Gujarat, India. FY 2026 financials & compliance.
CIN U24232GJ2007PTC050825 Incorporated 14 May 2007 ROC Ahmedabad HQ Padra, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹263.23 Cr
▲ 45% YoY
Net profit · FY 2025
₹44.86 Cr
Net margin 17%
EBITDA · FY 2025
₹87.09 Cr
EBITDA margin 33.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹84.8 Lakh
Issued & subscribed
Open charges
₹358.31 Cr
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
651
Provident fund records

About Apothecon Pharmaceuticals Private Limited

Data last updated:

Apothecon Pharmaceuticals Private Limited is a private limited company based in Padra, Gujarat, India, a subsidiary of Landmark Trade & Investments Limited (Mauritius). It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 14 May 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2007PTC050825. Its GSTIN is 24AACCN5414C1Z1 (Gujarat). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹84.8 Lakh. It was formerly known as Navinta Healthcare Private Limited. It is led by directors including Dilipkumar Ramsingbhai Parmar (Whole-Time Director) and Rajajeyakumar (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.1134 To 1137 1138 A&B 1143 A&B 1144 A&B Padra – Jambusar Highway At & Post: – Dabha, Sa, Gujarat, India – 391440.

As per the financials filed for FY 2025, the company reported a revenue of ₹263.23 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹44.86 Cr (net margin 17%) and EBITDA of ₹87.09 Cr (EBITDA margin 33.1%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 27% over five years.

The company has about 651 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Apothecon Pharmaceuticals. As per MCA filings, the company has open charges of ₹358.31 Cr on record. Court records list 22 cases involving the company, including 11 filed by the company and 11 filed against it; 2 cases are pending. The company has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹66.18 Cr; the latest was in February 2025. The company has 12 MSME Form 1 returns on record between 2022 and 2024, listing 1,462 overdue payments to 123 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apotheconpharma.com.

Company details

CIN U24232GJ2007PTC050825
Registration Number 050825
Incorporation Date 14 May 2007
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Landmark Trade & Investments Limited (Mauritius)
Compliance Status Active Compliant

Contact details

Apothecon Pharmaceuticals Private Limited's registered office is in Padra, Gujarat. Its website is apotheconpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No.1134 To 1137 1138 A&B 1143 A&B 1144 A&B Padra – Jambusar Highway At & Post: – Dabha, Sa, Gujarat, India – 391440
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Apothecon Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Apothecon Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Apothecon Pharmaceuticals operates one associated brand: Apothecon Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing of active pharmaceutical ingredients and formulations in the healthcare sector.apotheconpharma.com

Business activity

The main business activities of Apothecon Pharmaceuticals are professional, scientific and technical, manufacturing and trade. In detail, this covers scientific research and development, chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 3 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Apothecon Pharmaceuticals Private Limited, buy the company report.

Financials of Apothecon Pharmaceuticals Private Limited

FY 2025 filings available

Apothecon Pharmaceuticals Private Limited reported revenue of ₹263.23 Cr (up 45% YoY) for FY 2025.

Revenue · FY 2025
₹263.23 Cr ▲ 45%
Net profit · FY 2025
₹44.86 Cr margin 17%
EBITDA · FY 2025
₹87.09 Cr margin 33.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 45%
3 years · compounded
▲ 23%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 76%
3 years · compounded
▲ 23%
5 years · compounded
▲ 22%

Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 45% growth in the latest year. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹87.09 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹44.86 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin33.1%
Net Profit Margin17%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Apothecon Pharmaceuticals Private Limited, buy the company report.

Board of directors of Apothecon Pharmaceuticals Private Limited

Apothecon Pharmaceuticals has 3 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Dilipkumar Ramsingbhai ParmarWhole-Time Director30 Jun 20206 Years 3 MonthsCurrent
RajajeyakumarWhole-Time Director01 Jul 20179 Years 3 MonthsCurrent
Jayeshkumar Kodarlal JoshiDirector15 Apr 20233 Years 6 MonthsCurrent

Auditor

Apothecon Pharmaceuticals Private Limited is audited by Parikh &Majmudar for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Parikh &MajmudarFY 2024107525W

Shareholding

The shareholding of Apothecon Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Apothecon Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹358.31 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹338.41 Cr
Hdfc Bank Limited₹19.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Nov 2025101187236Hdfc Bank Limited₹12.66 LakhOpen
29 Aug 2025101146354Hdfc Bank Limited₹44.72 LakhOpen
19 Jul 2025101128900Hdfc Bank Limited₹21.2 LakhOpen
25 Mar 2025101077271Hdfc Bank Limited₹18 CrOpen
27 Jan 2025101039061State Bank of India₹78 CrOpen

To see the full charge records of Apothecon Pharmaceuticals Private Limited, buy the company report.

Total charge records: 10 View all charges

Deals & funding

Apothecon Pharmaceuticals Private Limited has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹66.18 Cr; the latest was in February 2025.

Total deals
8
Funding rounds
5
Secondary share transfers
3
Disclosed funding
₹66.18 Cr

Deals on record (5 of 8)

WhenDealAmountParties
Feb 2025Funding round₹5.04 CrInvestors: Landmark Trade & Investment Limited
Dec 2019Secondary share transferUndisclosedBuyer: Landmark Trade & Investment Limited
Seller: 4 individuals
Nov 2019Funding round₹3.9 CrInvestors: Landmark Trade & Investment Limited
Nov 2019Secondary share transferUndisclosedBuyer: 4 individuals
Seller: an individual
Apr 2018Funding round₹12.96 CrInvestors: Landmark Trade & Investment Limited

To see the full deal history of Apothecon Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Apothecon Pharmaceuticals Private Limited was last rated by Crisil on 19 Aug 2020.

Rating agencyRated onRating
Crisil19 Aug 2020

To see the full credit ratings and regulatory alerts of Apothecon Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

Apothecon Pharmaceuticals Private Limited has 12 MSME Form 1 returns on record between 2022 and 2024, listing 1,462 overdue payments to 123 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 123)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
JM Inst O Mech
an individual supplier
an individual supplier

To see the full MSME payment records of Apothecon Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Apothecon Pharmaceuticals Private Limited has a workforce of 651 employees on its EPFO records as of Feb 17, 2025, across 1 active EPFO establishment.

Employee count
651
Active EPFO establishments
1
Employee growth
7.96%

GST

Apothecon Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
24AACCN5414C1Z1GujaratActive01 Jul 2017
36AACCN5414C1ZWTelanganaActive13 Jun 2023

To see the full GST registrations and return filing status of Apothecon Pharmaceuticals Private Limited, buy the company report.

Recent activity

Apothecon Pharmaceuticals Private Limited has 19 board changes on record since 2009: 4 appointments and 15 cessations. The latest: Rajeshkumar Thekadi ceased to be Director on 16 Apr 2023.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.13 Cr with Charge ID 101187236 was registered on 20 Nov 2025.
AGM
Apothecon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.45 Cr with Charge ID 101146354 was registered on 29 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 101128900 was registered on 19 Jul 2025.
Filing
Apothecon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 18.00 Cr with Charge ID 101077271 was registered on 25 Mar 2025.
Charges
A charge with State Bank Of India amounted to Rs. 78.00 Cr with Charge ID 101039061 was registered on 27 Jan 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.72 Cr with Charge ID 100982669 was registered on 03 Oct 2024.
Charges
A charge with State Bank Of India of Rs. 80.91 Cr registered on 18 Jan 2018 with Charge ID 100152581 was modified on 12 Sep 2024.
Charges
A charge with State Bank Of India amounted to Rs. 78.00 Cr with Charge ID 100953913 was registered on 24 Jul 2024.
Charges
A charge with State Bank Of India of Rs. 101.50 Cr registered on 18 Jan 2018 with Charge ID 100152588 was modified on 28 Dec 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 100791202 was registered on 04 Sep 2023.

22 earlier events are in the company report.

Frequently asked questions

Apothecon Pharmaceuticals is an active private limited company based in Padra, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 14 May 2007 (19+ years old) and is registered under CIN U24232GJ2007PTC050825.

Apothecon Pharmaceuticals has 3 current directors:

The latest financial statements of Apothecon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Apothecon Pharmaceuticals is 24AACCN5414C1Z1, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AACCN5414C1ZW (Telangana).

The CIN (Corporate Identification Number) of Apothecon Pharmaceuticals is U24232GJ2007PTC050825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Apothecon Pharmaceuticals has 22 court cases on record: 11 filed by the company and 11 filed against it. 2 are pending. Most are in the district courts.

Apothecon Pharmaceuticals was incorporated on 14 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Apothecon Pharmaceuticals has 8 deals on record (5 funding rounds, 3 secondary share transfers), with disclosed funding of ₹66.18 Cr; the latest was in February 2025.

Rajeshkumar Thekadi ceased to be Director on 16 Apr 2023. Jayeshkumar Kodarlal Joshi was appointed as Director on 15 Apr 2023. Pankaj Vasudev Parmar ceased to be Director on 07 Apr 2023. Apothecon Pharmaceuticals has 19 board changes on record in total.

Apothecon Pharmaceuticals has 12 MSME Form 1 returns on record between 2022 and 2024, listing 1,462 overdue payments to 123 micro and small suppliers. The latest return was filed on 30 Apr 2024.

Apothecon Pharmaceuticals can be reached through the website apotheconpharma.com. Its registered office is in Padra, Gujarat, India.